Dr. Jennifer E. Schwartz, MD

Dr. Schwartz practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Schwartz's NPI, 1881650356, was assigned on April 25, 2006. Dr. Schwartz graduated from McGill University Faculty of Medicine in 1997. Dr. Schwartz holds Indiana license 01057266A.

Dr. Schwartz's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Schwartz's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Schwartz is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Schwartz to 2 more hospitals, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Schwartz is licensed in Indiana.

Dmand AI lists chronic leukemia, immune deficiency disease and lymphoma among the conditions Dr. Schwartz treats.

CMS data shows 195 Medicare services from Dr. Schwartz across 3 procedure codes in 2024, for 79 Medicare patients. Medicare paid $13,595 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 43 patients. 65% of them have high blood pressure, and 43% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 58, with 50% women.

In 2024, Dr. Schwartz wrote 1,948 Medicare Part D claims for 97 patients. 77% of them were for generic drugs. CMS names the drug for 1,621 of them, across 43 drugs with 11 or more claims each, at $7,427,074 in total drug cost. In 2023, CMS named 407 claims across 19 drugs.

Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 20 papers to Dr. Schwartz, published from 2010 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Transplantation, Homologous. Dr. Schwartz has published most often in Acad Med. Dr. Schwartz's most frequent co-authors are Sherif S. Farag, MD, Rafat Abonour, MD and John William Baute, MD.

CMS Open Payments shows 10 general payments to Dr. Schwartz from 5 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 61% of the total. Daiichi Sankyo Inc. paid the most, $6,390.

Dr. Schwartz graduated from McGill University Faculty of Medicine in 1997.

Dr. Schwartz is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.